Form IRANNOTICE QIAGEN N.V.
Tweet
Share
E-mail
QIAGEN N.V.
Hulsterweg 82
5912 PL Venlo
The Netherlands
March 19, 2026
U.S. Securities and Exchange Commission
100 F Street, N.E.
Washington, DC 20549
Re: Notice of Disclosure Filed in Exchange Act Annual Report Under Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 and Section 13(r) of the Exchange Act
Ladies and Gentlemen:
Pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 and Section 13(r) of the Securities Exchange Act of 1934, as amended, notice is hereby provided that QIAGEN N.V. has made disclosure pursuant to such provisions in its Annual Report on Form 20-F for the fiscal year ended December 31, 2025, which was filed with the U.S. Securities and Exchange Commission on March 19, 2026.
Sincerely,
| /s/ Roland Sackers | ||
Roland Sackers | ||
Chief Financial Officer | ||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Qiagen NV (QGEN) Reiterated at Hold by Stifel Post QIAcuity digital PCR Deep-Dive
- Faraday Future Unveils Its Second-Half Launch of the FF EAI Robot World, Including the Launch of Its New Mobile Manipulator, the All-New Futurist, and a Preview of FF’s EAI Robotics Industrial Ecosy
- Signify Enhances Philips Hue Matter Support Through Collaboration with Silicon Labs
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
